Belkacem Acidi, Alain Sauvanet, Giovanni Marchegianni, Hop S. Tran Cao, Sébastien Gaujoux
{"title":"Optimal intraoperative management in pancreatic surgery: a systematic review of randomized controlled trials","authors":"Belkacem Acidi, Alain Sauvanet, Giovanni Marchegianni, Hop S. Tran Cao, Sébastien Gaujoux","doi":"10.1016/j.hpb.2026.05.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Despite major advances in pancreatic surgery and reduced mortality, intraoperative management remains poorly standardized and largely dependent on surgeon expertise. This systematic review aimed to synthesise randomized controlled trials evaluating intraoperative surgical techniques in pancreatic surgery and their impact on predefined postoperative outcomes (POPF, DGE, SSI, and length of stay).</div></div><div><h3>Methods</h3><div>Following PRISMA guidelines, a comprehensive search of PubMed, EMBASE, and the Cochrane Database (2013–2024) identified RCTs assessing intraoperative management in pancreatic surgery. Studies focusing on oncologic outcomes or including fewer than 60 patients were excluded. Quality and risk of bias were assessed using the Jadad Scale and the Cochrane RoB-2 tool.</div></div><div><h3>Results</h3><div>Of 818 articles screened, 47 RCTs met inclusion criteria (Jadad ≥3). Postoperative pancreatic fistula (POPF) was the primary endpoint in 19 studies. Significant POPF reductions were associated with specific techniques such as end-to-side anastomosis, pancreaticogastrostomy, and polyethylene glycol–coated patches. Minimally invasive distal pancreatectomy showed reduced blood loss, hospital stay, and faster recovery. Selective or no-drain policies in distal pancreatectomy were supported by RCTs to reduce clinically relevant POPF.</div></div><div><h3>Conclusion</h3><div>Intraoperative management in pancreatic surgery remains heterogeneous. Standardized, evidence-based protocols and additional high-quality RCTs are required to optimize surgical techniques and outcomes.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Pages 1116-1124"},"PeriodicalIF":3.3000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hpb","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1365182X26006155","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Despite major advances in pancreatic surgery and reduced mortality, intraoperative management remains poorly standardized and largely dependent on surgeon expertise. This systematic review aimed to synthesise randomized controlled trials evaluating intraoperative surgical techniques in pancreatic surgery and their impact on predefined postoperative outcomes (POPF, DGE, SSI, and length of stay).
Methods
Following PRISMA guidelines, a comprehensive search of PubMed, EMBASE, and the Cochrane Database (2013–2024) identified RCTs assessing intraoperative management in pancreatic surgery. Studies focusing on oncologic outcomes or including fewer than 60 patients were excluded. Quality and risk of bias were assessed using the Jadad Scale and the Cochrane RoB-2 tool.
Results
Of 818 articles screened, 47 RCTs met inclusion criteria (Jadad ≥3). Postoperative pancreatic fistula (POPF) was the primary endpoint in 19 studies. Significant POPF reductions were associated with specific techniques such as end-to-side anastomosis, pancreaticogastrostomy, and polyethylene glycol–coated patches. Minimally invasive distal pancreatectomy showed reduced blood loss, hospital stay, and faster recovery. Selective or no-drain policies in distal pancreatectomy were supported by RCTs to reduce clinically relevant POPF.
Conclusion
Intraoperative management in pancreatic surgery remains heterogeneous. Standardized, evidence-based protocols and additional high-quality RCTs are required to optimize surgical techniques and outcomes.
期刊介绍:
HPB is an international forum for clinical, scientific and educational communication.
Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.
Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.
HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.
Abstracted and Indexed in:
MEDLINE®
EMBASE
PubMed
Science Citation Index Expanded
Academic Search (EBSCO)
HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).